Restructuring Charges

6 Months Ended

Jun. 30, 2013

(6)	Restructuring Charges

During the six months ended June 30, 2013, the Company implemented restructurings of its workforce to better focus the Company’s organizational structure, increase efficiency and concentrate financial resources on its clinical development program and European commercialization activity. This resulted in a reduction in the Company’s workforce by 27 employees. As a result of termination benefits given to the impacted employees, the restructuring activities resulted in a total cost of approximately $1.5 million which is reflected on the Condensed Consolidated Statements of Operations in both “Selling, general and administrative expenses” and “Research and development expenses”, as appropriate. The $1.1 million in accrued severance expenses at June 30, 2013 is included in “Accrued Expenses” on the Condensed Consolidated Balance Sheets.

(in thousands)	June 30, 2013
Severance and restructuring expenses	$	1,470
Restructuring expenses paid by June 30, 2013		(376	)
Total restructuring expenses accrued as of June 30, 2013	$	1,094

Of the $1.1 million of severance payments remaining in accruals, approximately $0.9 million will be paid out through June 2014.

- Definition

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

+ References+ Details